Modi S, Park H, Murthy RK, Iwata H, et al. Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study. J Clin Oncol 2020 Feb 14:JCO1902318. doi: 10.1200/JCO.19.02318.
PMID: 32058843